This 3-day forum is the “must attend” event for those senior decision-makers looking to drive their medical affairs teams and departments and enhance their KOL & stakeholder engagement at all levels.

The first day will feature several keynote presentations from VP-Level thought leaders on shaping and leading the medical affairs departments, justifying medical affairs performance through innovative metrics and tracking effectiveness of the function as an essential element of today’s pharmaceutical companies. They will be discussing the strategic drivers for medical affairs, and guidance on how to make best use of this vital function.

Day 2 of the Forum will feature 2 specific streams depending on your specific needs:

Stream 1: Enhancing Medical Communications for Medical Affairs – Medical Affairs departments are increasingly looking to implement next generation medical communication practices, to offer essential evidence-based information to stakeholders on demand, through a variety of classical, yet also increasingly digital channels. This stream will focus on two key aspects of medical communication. Firstly, issues such as: protocol writing for internal late-phase studies and research initiatives; working with External Experts (KOLs) to enhance publications, abstracts & posters and receiving proposals for investigator-initiated studies. The second section of this day will focus on Medical Scientific Marketing communications, including the review process, compliance issues, ensuring the claims made by marketing colleagues are justified and appropriately communicated and also effectively localized from global-level to country-level market requirements.

Stream 2: Real-World Evidence Generation for Medical Affairs – Generating real world evidence via observational studies and the use of patient registries is one of the fastest growing areas of pharmaceutical R&D. Such post-marketing studies are becoming increasingly important as regulatory agencies and payers demand more long-term data which demonstrates efficacy, safety and quality. The Medical Affairs unit plays a decisive role in generating this vital evidence and this stream will present solutions to the challenges companies face in generating high-quality evidence which will communicate a compelling value argument to all necessary stakeholders requirements.

Day 3: MedAffairs: MedTech

This session focuses on the fast-evolving role of medical affairs specifically for MedTech companies and the increasingly important need for this function which facilitates overall corporate performance. The different business model of MedTech vs Pharma, necessitates an adjustment in the way KOLs, external experts & patients are engaged with and communicated to. This highly-popular, 1-day stream is back and with new speakers, will enable the MedTech community to get the most out of their medical affairs teams and develop a more patient-centric business model.

Along with our exclusive networking dinner for all participants, the event will feature excellent networking opportunities and the chance to strengthen your contacts within the Medical Affairs community. The 2017 event was a sell-out so please make sure you book early to avoid disappointment.

Request agenda here for complete speaker list

Pharma & Biotech Industry Experts

Head of Global Medical Affairs Excellence
GSK, UK

EMEA Medical Lead Neurology & Immunology
Merck Group, Belgium

Vice President, Medical Affairs
Norgine

Senior Director Regional Medical Affairs International Developed Markets (IDM): Europe, Japan, Korea,
Pfizer, Germany

Director Medical Affairs - Global Med. Strategic Acute Care,
MSD, Switzerland

Head of Medical Affairs & Patient Advocacy
Ultragenyx, Switzerland

VP - Head Strategic Planning and Digital Practices, Global Medical Affairs
GSK, UK

Senior Manager Scientific Communications
Amgen, Germany

Head of Medical Affairs
Nordic Nanovector, Switzerland

Global Digital Marketing Lead
Norgine, UK

Associate Director Medical Affairs, Russia & Eurasia
Teva, Russia

Director, Real World Evidence Global Patient Outcomes and Real World Evidence (GPORWE) International
Eli Lilly, Belgium

Head Medical Affairs
Biogen, Switzerland

 

MedTech Industry Experts

Chief Medical Officer Europe, Middle East and Africa
Medtronic, Switzerland

Director, Medical & Scientific Affairs
Boston Scientific, USA

Chief Medical Officer & Head of Market Access
Molnlycke Health Care, Sweden

Vice President, Head Global Clinical Strategy
Smith & Nephew, Switzerland

Global Medical Director
Abbott Structural Heart, Belgium

Global Director Scientific Communications | Medical Affairs
Medtronic, France

Medical Affairs Manager EP, Europe
Boston Scientific, Germany

Medical Affairs Manager, EMEA
Alcon, Switzerland

 

Patients & Stakeholders

Head of Research and Development, St Andrew's Healthcare
Committee for Advanced Therapies, Member, EMA, UK

Founder
Patient Information Forum, UK

President and Patient Advocate
Inspire2Live, Netherlands

Patient Advocate
European AIDS Treatment Group (EATG), Switzerland

Writer, Patient Empowerment Network
Director, Health Care Social Media Monitor, Ireland

CEO
Tonic App, Portugal

Director of Digital Engagement and Communications
The Brain Tumour Charity, UK

Digital Communication Manager
Geneva University Hospitals, Switzerland

Founder & CEO
aparito, UK

Business Development Director
HealthUnlocked, UK

 

Expert Solution Providers

Director of Scientific Services
Complete HealthVizion

Managing Director
Succinct Medical Communications

Exec Dir, Client Engagement
Syneos Health, UK

Chief Medical Officer, Director of Real World Evidence and Health Economics
LINK Medical Research, Norway

 

 

 

 

 

Request agenda here for complete speaker list

Pictures from recent MedAffairs Leaders Forums. Imagine being there...

The first day will feature several keynote presentations from VP-Level thought leaders on shaping and leading the medical affairs departments, justifying medical affairs performance through innovative metrics and tracking effectiveness of the function as an essential element of today’s pharmaceutical companies. They will be discussing the strategic drivers for medical affairs, and guidance on how to make best use of this vital function.

SPEAKER LIST - DAY 1

Head of Global Medical Affairs Excellence
GSK, UK

EMEA Medical Lead Neurology & Immunology
Merck Group, Belgium

Head of Medical Affairs
Nordic Nanovector, Switzerland

Senior Director Regional Medical Affairs International Developed Markets (IDM): Europe, Japan, Korea,
Pfizer, Germany

Head of Medical Affairs & Patient Advocacy
Ultragenyx, Switzerland

Head of Research and Development, St Andrew's Healthcare
Committee for Advanced Therapies, Member, EMA, UK

Founder
Patient Information Forum, UK

President and Patient Advocate
Inspire2Live, Netherlands

Patient Advocate
European AIDS Treatment Group (EATG), Switzerland

Writer, Patient Empowerment Network
Director, Health Care Social Media Monitor, Ireland

Medical Affairs departments are increasingly looking to implement next generation medical communication practices, to offer essential evidence-based information to stakeholders on demand, through a variety of classical, yet also increasingly digital channels. This stream will focus on two key aspects of medical communication. Firstly, issues such as: protocol writing for internal late-phase studies and research initiatives; working with External Experts (KOLs) to enhance publications, abstracts & posters and receiving proposals for investigator-initiated studies. The second section of this day will focus on Medical Scientific Marketing communications, including the review process, compliance issues, ensuring the claims made by marketing colleagues are justified and appropriately communicated and also effectively localized from global-level to country-level market requirements.

SPEAKER LIST - DAY 2 - STREAM 1

VP - Head Strategic Planning and Digital Practices, Global Medical Affairs
GSK, UK

Senior Manager Scientific Communications
Amgen, Germany

Director of Scientific Services
Complete HealthVizion

Head Medical Affairs
Biogen, Switzerland

Managing Director
Succinct Medical Communications

Global Digital Marketing Lead
Norgine, UK

CEO
Tonic App, Portugal

Director of Digital Engagement and Communications
The Brain Tumour Charity, UK

Digital Communication Manager
Geneva University Hospitals, Switzerland

Associate Director Medical Affairs, Russia & Eurasia
Teva, Russia

 

 

 

 

Generating real world evidence via observational studies and the use of patient registries is one of the fastest growing areas of pharmaceutical R&D. Such post-marketing studies are becoming increasingly important as regulatory agencies and payers demand more long-term data which demonstrates efficacy, safety and quality. The Medical Affairs unit plays a decisive role in generating this vital evidence and this stream will present solutions to the challenges companies face in generating high-quality evidence which will communicate a compelling value argument to all necessary stakeholders requirements.

SPEAKER LIST - DAY 2 - STREAM 2

Founder & CEO
aparito, UK

Business Development Director
HealthUnlocked, UK

Director Medical Affairs - Global Med. Strategic Acute Care,
MSD, Switzerland

Exec Dir, Client Engagement
Syneos Health, UK

Chief Medical Officer, Director of Real World Evidence and Health Economics
LINK Medical Research, Norway

Director, Real World Evidence Global Patient Outcomes and Real World Evidence (GPORWE) International
Eli Lilly, Belgium

Vice President, Medical Affairs
Norgine

Medical Affairs Manager, EMEA
Alcon, Switzerland

 

 

 

This session focuses on the fast-evolving role of Medical Affairs specifically for MedTech companies and the increasingly important need for this function which facilitates overall corporate performance. The different business model of MedTech vs Pharma, necessitates an adjustment in the way KOLs, external experts & patients are engaged with and communicated to. This highly-popular, 1-day stream is back and with new speakers, will enable the MedTech community to get the most out of their Medical Affairs teams and develop a more patient-centric business model.

SPEAKER LIST - DAY 3

Chief Medical Officer Europe, Middle East and Africa
Medtronic, Switzerland

Director, Medical & Scientific Affairs
Boston Scientific, USA

Chief Medical Officer & Head of Market Access
Molnlycke Health Care, Sweden

Vice President, Head Global Clinical Strategy
Smith & Nephew, Switzerland

Global Medical Director
Abbott Structural Heart, Belgium

Global Director Scientific Communications | Medical Affairs
Medtronic, France

Medical Affairs Manager EP, Europe
Boston Scientific, Germany

 

This event will provide all delegates the chance to meet one another through our many networking opportunities. With pre-event, mid-morning and mid-afternoon breaks as a standard, this event will also feature a complimentary networking dinner for all participants.

This evening will allow you to meet with our expert speaker panel who represent many stakeholder groups in a less formal setting. Our networking lunches will also allow you plenty of time to meet with your peers and colleagues whilst you refuel through the event.

PHARMA & MEDICAL DEVICE: VPs, Directors & Managers of:

Customer Relations, Medical Affairs, Medical Science Liaisons, Medical Education, Health Outcomes & Liaison, Medical Communications, Marketing, KOL & Stakeholder Engagement, Late Phase & Real-World Research, Scientific Affairs, Medical Advisors and Patient-Centricity.

Event Partners

Event Educational Partner

Media Partners

This event is accredited for CPD (Continuing Professional Development) status

RECEIVE DISCOUNTED FLIGHTS WHEN YOU REGISTER FOR THIS EVENT WITH

Share with Colleagues